These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23072840)

  • 1. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
    Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
    Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
    Schmidt M; Hasenclever D; Schaeffer M; Boehm D; Cotarelo C; Steiner E; Lebrecht A; Siggelkow W; Weikel W; Schiffer-Petry I; Gebhard S; Pilch H; Gehrmann M; Lehr HA; Koelbl H; Hengstler JG; Schuler M
    Clin Cancer Res; 2008 Sep; 14(18):5849-55. PubMed ID: 18794096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Simon R; Spichtin H; Maurer R; Metzger U; von Castelberg B; Bart R; Stopatschinskaya S; Köchli OR; Haas P; Mross F; Zuber M; Dietrich H; Bischoff S; Mirlacher M; Sauter G; Gastl G
    Breast Cancer Res Treat; 2004 Aug; 86(3):207-13. PubMed ID: 15567937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
    Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
    Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.
    Schmidt M; Petry IB; Böhm D; Lebrecht A; von Törne C; Gebhard S; Gerhold-Ay A; Cotarelo C; Battista M; Schormann W; Freis E; Selinski S; Ickstadt K; Rahnenführer J; Sebastian M; Schuler M; Koelbl H; Gehrmann M; Hengstler JG
    Breast Cancer Res Treat; 2011 Feb; 125(3):637-46. PubMed ID: 20352488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
    Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
    Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
    J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients.
    Srivastava G; Assi J; Kashat L; Matta A; Chang M; Walfish PG; Ralhan R
    BMC Cancer; 2014 Sep; 14():726. PubMed ID: 25265904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
    Wang G; Zhang Z; Ren Y
    Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
    Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
    BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
    J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ep-CAM overexpression in breast cancer as a predictor of survival.
    Gastl G; Spizzo G; Obrist P; Dünser M; Mikuz G
    Lancet; 2000 Dec; 356(9246):1981-2. PubMed ID: 11130529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
    Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
    BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ep-CAM, but not of E48, associates with nodal involvement in advanced squamous cell carcinomas of the larynx.
    Romeu C; Farré X; Cardesa A; Nadal A
    Histopathology; 2013 May; 62(6):954-61. PubMed ID: 23672314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
    Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
    Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
    Akita H; Nagano H; Takeda Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Takahashi H; Ohigashi H; Tomita Y; Ishikawa O; Mori M; Doki Y
    Oncogene; 2011 Aug; 30(31):3468-76. PubMed ID: 21399662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trop-2 is a determinant of breast cancer survival.
    Ambrogi F; Fornili M; Boracchi P; Trerotola M; Relli V; Simeone P; La Sorda R; Lattanzio R; Querzoli P; Pedriali M; Piantelli M; Biganzoli E; Alberti S
    PLoS One; 2014; 9(5):e96993. PubMed ID: 24824621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
    Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
    Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.